stonks4u
Sign up free
MRNA logo

MRNA Moderna, Inc.

NASDAQ Global Select · Biotechnology · Healthcare

$63.32
-0.33 (-0.52%)

Moderna, Inc., a biotechnology firm, is dedicated to the discovery, development, and commercialization of messenger RNA (mRNA) based therapies and preventive medicines. Its extensive research and development efforts target a broad spectrum of medical needs, including infectious diseases, cancer immunology, rare conditions, cardiovascular ailments, and autoimmune disorders, with operations spanning…

Market Cap: $25.12Bwww.modernatx.com

Price (90d)

$59.17
$45.37$57.51$69.66$81.80
Apr 30Aug 7

Signal Score (90d)

43
4379114150
Aug 8Aug 13

Quote

Day Range
$60.82 – $63.78
52-Week Range
$22.28 – $85.60
Volume
$4.69M
Market Cap
$25.12B
50-Day Avg
$60.81
200-Day Avg
$46.48
Prev Close
$63.65
Open
$62.71

Valuation & Ratios

P/E Ratio
-4.06
EPS
$-7.25
P/B Ratio
1.33
P/S Ratio
5.90
Debt/Equity
0.22
Current Ratio
3.29
Dividend Yield
+0.0%
Gross Margin
+55.3%

Returns & Efficiency

Return on Equity
-32.6%
Return on Assets
-22.9%
FCF Yield
-18.0%
EV/EBITDA
-4.23

Revenue & Net Income (Annual)

Fiscal YearRevenueNet IncomeEPS
2025$1.94B$-2.82B$-7.26
2024$3.20B$-3.56B$-9.27
2023$6.85B$-4.71B$-12.34
2022$18.88B$8.36B$21.26
2021$17.74B$12.20B$30.31

Social Signal Score

48
5d
44
1 mentions
+0.0%
30d
50
4 mentions
-6.3%
60d
50
4 mentions
+6.8%
90d
50
4 mentions
+20.7%
4chan: 3 · podcast: 1

Earnings

Thu, Nov 5(in 3 months)

Consensus estimate $-1.38 per share

7of 7 quarters beat consensus

Typical surprise +16.9% (median, so one quarter with a near-zero estimate can't distort it)

  • Fri, Jul 31$-1.97 vs $-2.03beat
  • Fri, May 1$-3.40 vs $-4.45beat
  • Fri, Feb 13$-2.11 vs $-2.54beat
  • Thu, Nov 6$-0.51 vs $-1.87beat
  • Fri, Aug 1$-2.13 vs $-2.99beat
  • Thu, May 1$-2.52 vs $-2.92beat

Estimates and results for MRNA via Financial Modeling Prep. Beating consensus says the company cleared the bar analysts set, not that the business grew.

Valuation

MRNAhas no positive reported earnings per share, so an earnings-multiple projection can't be built for it. Companies are valued on other measures at this stage — revenue growth, cash burn, or book value — none of which this calculator models.

Mentions (4)

  • PodcastAll In·2d ago·Neutral

    … their efficacy is in the 60%. And we know for a fact that a lot of Chinese leaders were not taking the Chinese vaccine, but they were end up taking quietly, Pfizer, Moderna, etc. And they couldn't export the vaccine. Nobody in the third world, that's a huge opportunity for America. We squandered it. I'm a political side of the economic side of the cultural side. Winning, quote unquote, the global side. Second, gene makes a decision that will never happen again. Massively invests in the life sci…

    View source ↗
  • 4chan /biz/biz·7d ago·Neutral

    >>62575555 >droopy face/myocarditis The actual incidence of myocarditis was very low as we know from the Israel population studies and groups as risk (young men) were recommended Biontech instead of Moderna anyway. Covid itself also caused myocarditis amongst other symptoms.

    View source ↗
  • 4chan /biz/biz·7d ago·Neutral

    >>62575498 You mean antivaxxers on twitter pretending they have ever worked at Moderna and aren't just blue-collar white MIGA trash?

    View source ↗
  • 4chan /biz/biz·7d ago·Neutral

    >>62575494 Why would you want to murder Moderna employees?

    View source ↗